MarketsMerck, AstraZeneca Lynparza wins restricted label growth endorsement admin2 years ago01 mins Merck, AstraZeneca Lynparza wins restricted label growth endorsement Post navigation Previous: NFTouring’s ICO (NFTR) is within the highlight. Why’s that? Next: UPDATE 3-Securitas grows earnings regardless of labour shortages